» Articles » PMID: 34818069

Feedback Loop Regulation Between Pim Kinases and Tax Keeps Human T-Cell Leukemia Virus Type 1 Viral Replication in Check

Overview
Journal J Virol
Date 2021 Nov 24
PMID 34818069
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The Pim family of serine/threonine kinases promote tumorigenesis by enhancing cell survival and inhibiting apoptosis. Three isoforms exist, Pim-1, -2, and -3, that are highly expressed in hematological cancers, including Pim-1 in adult T-cell leukemia (ATL). Human T-cell leukemia virus type-1 (HTLV-1) is the etiological agent of ATL, a dismal lymphoproliferative disease known as adult T-cell leukemia. The HTLV-1 virally encoded oncogene Tax promotes CD4 T-cell transformation through disruption of DNA repair pathways and activation of survival and cellular proliferation pathways. In this study, we found Tax increases the expression of Pim-1 and Pim-3, while decreasing Pim-2 expression. Furthermore, we discovered that Pim-1, -2, and -3 bind Tax protein to reduce its expression thereby creating a feedback regulatory loop between these two oncogenes. The loss of Tax expression triggered by Pim kinases led to loss in Tax-mediated transactivation of the HTLV-1 long terminal repeat (LTR) and reductions in HTLV-1 virus replication. Because Tax is also the immunodominant cytotoxic T cell lymphocytes (CTL) target, our data suggest that Pim kinases may play an important role in immune escape of HTLV-1-infected cells. The Pim family of protein kinases have established pro-oncogenic functions. They are often upregulated in cancer; especially leukemias and lymphomas. In addition, a role for Pim kinases in control of virus expression and viral latency is important for Kaposi sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus type 1 (HIV-1). Our data demonstrate that HTLV-1 encodes viral genes that promote and maintain Pim kinase activation, which in turn may stimulate T-cell transformation and maintain ATL leukemic cell growth. HTLV-1 Tax increases expression of Pim-1 and Pim-3, while decreasing expression of Pim-2. In ATL cells, Pim expression is maintained through extended protein half-life and heat shock protection. In addition, we found that Pim kinases have a new role during HTLV-1 infection. Pim-1, -2, and -3 can subvert Tax expression and HTLV-1 virus production. This may lead to partial suppression of the host immunogenic responses to Tax and favor immune escape of HTLV-1-infected cells. Therefore, Pim kinases have not only pro-oncogenic roles but also favor persistence of the virus-infected cell.

Citing Articles

Current State of Therapeutics for HTLV-1.

Wang T, Hirons A, Doerflinger M, Morris K, Ledger S, Purcell D Viruses. 2024; 16(10).

PMID: 39459949 PMC: 11512412. DOI: 10.3390/v16101616.


Trans-Activation of the () Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.

Hayati R, Nakajima R, Zhou Y, Shirasawa M, Zhao L, Fikriyanti M Genes (Basel). 2024; 15(6).

PMID: 38927636 PMC: 11202806. DOI: 10.3390/genes15060698.


Increased /miR-675 Expression in Adult T-Cell Leukemia Is Associated with a Unique Notch Signature Pathway.

Bellon M, Nicot C Int J Mol Sci. 2024; 25(10).

PMID: 38791169 PMC: 11120950. DOI: 10.3390/ijms25105130.


Targeting Pim kinases in hematological cancers: molecular and clinical review.

Bellon M, Nicot C Mol Cancer. 2023; 22(1):18.

PMID: 36694243 PMC: 9875428. DOI: 10.1186/s12943-023-01721-1.


Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.

El Hajj H, Bazarbachi A Front Immunol. 2022; 13:957535.

PMID: 35935975 PMC: 9352851. DOI: 10.3389/fimmu.2022.957535.

References
1.
Kinoshita T, Shimoyama M, Tobinai K, Ito M, Ito S, Ikeda S . Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989; 86(14):5620-4. PMC: 297674. DOI: 10.1073/pnas.86.14.5620. View

2.
Keane N, Reidy M, Natoni A, Raab M, ODwyer M . Targeting the Pim kinases in multiple myeloma. Blood Cancer J. 2015; 5:e325. PMC: 4526774. DOI: 10.1038/bcj.2015.46. View

3.
Bellon M, Nicot C . Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood. 2008; 112(7):2946-55. PMC: 2556626. DOI: 10.1182/blood-2008-01-134692. View

4.
Mikovits J, Ruscetti F, Zhu W, Bagni R, Dorjsuren D, Shoemaker R . Potential cellular signatures of viral infections in human hematopoietic cells. Dis Markers. 2002; 17(3):173-8. PMC: 3850588. DOI: 10.1155/2001/896953. View

5.
Rainio E, Ahlfors H, Carter K, Ruuska M, Matikainen S, Kieff E . Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. Virology. 2005; 333(2):201-6. DOI: 10.1016/j.virol.2005.01.001. View